Oncolytic virotherapy-mediated anti-tumor response: a single-cell perspective
- 21 January 2021
- journal article
- research article
- Published by Elsevier BV in Cancer Cell
- Vol. 39 (3), 394-406.e4
- https://doi.org/10.1016/j.ccell.2020.12.022
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- BLUEPRINT: mapping human blood cell epigenomesHaematologica, 2013
- An integrated encyclopedia of DNA elements in the human genomeNature, 2012
- Analyses of phenotypic and functional characteristics of CX3CR1‐expressing natural killer cellsImmunology, 2011
- PANTHER version 7: improved phylogenetic trees, orthologs and collaboration with the Gene Ontology ConsortiumNucleic Acids Research, 2009
- Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009Cell Death & Differentiation, 2008
- HVEM and Nectin-1 Are the Major Mediators of Herpes Simplex Virus 1 (HSV-1) Entry into Human Conjunctival EpitheliumInvestigative Ophthalmology & Visual Science, 2008
- The inhibitory cytokine IL-35 contributes to regulatory T-cell functionNature, 2007
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour propertiesGene Therapy, 2003
- Association of Herpes Simplex Virus Type 1 ICP8 and ICP27 Proteins with Cellular RNA Polymerase II HoloenzymeJournal of Virology, 2002